CSL signs up Thermo Fisher in biologics development and manufacturing deal
CDMO will operate new Swiss facility due for completion in 2021 to support production of next-gen haemophilia product
Contract development and manufacturing organisation Thermo Fisher Scientific has entered into a strategic development and manufacturing partnership with CSL to meet the biotech company’s growing demand for flexible biologics capacity, the two companies said on Wednesday.
Under the terms of the agreement, CSL will have access to Thermo Fisher’s pharma services network, including drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics.
And through a long-term lease agreement with CSL, Thermo Fisher will operate a new biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in mid-2021.
Within the Lengnau site, Thermo Fisher will support manufacturing of CSL's next-generation product for haemophilia patients. The site will feature flexible bioproduction technologies, including single-use and stainless steel, from development to large-scale production.
Thermo Fisher said it plans to expand the use of the site to include additional biopharma customers.
Michel Lagarde, executive vice president of Thermo Fisher Scientific said the Lengnau facility would significantly expand the firm’s pharma services capacity and capabilities.
“In addition to adding a high-volume production site, we can also address a broadening range of manufacturing needs for our customers, including CSL,” he added.
Paul McKenzie, chief operating officer, CSL, said that as part of the CSL board’s strategic review, the company is in the process of transforming its end-to-end supply chain to ensure its global manufacturing network is operating at a best-in-class level.
“This includes balancing internal investment with access to capabilities and capacities that are available with an experienced partner,” he said.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance